Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

201
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
201
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

584
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
584
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

5.1K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.1K
EDTA: Auxiliary Complexing Reagents01:26

EDTA: Auxiliary Complexing Reagents

633
EDTA titrations are usually carried out in highly basic conditions, where the fully deprotonated form of EDTA, Y4−, actively complexes with the free metal ions in the solution. Several metal ions precipitate as hydrous oxide (hydroxides, oxides, or oxyhydroxides) under these conditions, lowering the concentration of free metal ions in the solution. For this reason, auxiliary complexing agents or ligands such as ammonia, tartrate, citrate, or triethanolamine are used in EDTA titrations to...
633
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

716
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
716
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

1.5K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coordinated pre-mRNA processing at the single-transcript level.

Trends in genetics : TIG·2026
Same author

Something old, something new? Herpesvirus genome packaging examined in light of lessons from the tailed bacteriophages.

Journal of virology·2026
Same author

Efficient co-transcriptional splicing enforces rapid microexon definition and inclusion by SRRM4.

bioRxiv : the preprint server for biology·2026
Same author

The Kaposi's sarcoma-associated herpesvirus viral genome packaging accessory factor ORF68 forms cytoplasmic puncta dependent on the viral tyrosine kinase.

bioRxiv : the preprint server for biology·2026
Same author

Transcriptional readthrough precedes alternative splicing programs triggered in CML cells by imatinib.

Science advances·2026
Same author

Comparative RNA Structure Analysis of Nascent and Mature Transcripts in Saccharomyces cerevisiae.

Journal of visualized experiments : JoVE·2026

Related Experiment Video

Updated: Jul 31, 2025

Exploring the Arginine Methylome by Nuclear Magnetic Resonance Spectroscopy
07:02

Exploring the Arginine Methylome by Nuclear Magnetic Resonance Spectroscopy

Published on: December 16, 2021

1.5K

Tudor-dimethylarginine interactions: the condensed version.

Daniela Šimčíková1, Sara Gelles-Watnick1, Karla M Neugebauer1

  • 1Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520, USA.

Trends in Biochemical Sciences
|May 8, 2023
PubMed
Summary

Biomolecular condensates (BMCs) form via noncovalent interactions. This study investigates Tudor domain proteins, like SMN, binding to dimethylarginine (DMA) modifications, crucial for BMCs and linked to spinal muscular atrophy (SMA).

Keywords:
SMN proteinTudor domainbiomolecular condensatedimethylarginineribonucleoprotein particlespinal muscular atrophy

More Related Videos

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

43.8K
Measurement of Cyclic Guanosine Monophosphate (cGMP) in Solid Tissues using Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
07:15

Measurement of Cyclic Guanosine Monophosphate (cGMP) in Solid Tissues using Competitive Enzyme-Linked Immunosorbent Assay (ELISA)

Published on: July 3, 2025

167

Related Experiment Videos

Last Updated: Jul 31, 2025

Exploring the Arginine Methylome by Nuclear Magnetic Resonance Spectroscopy
07:02

Exploring the Arginine Methylome by Nuclear Magnetic Resonance Spectroscopy

Published on: December 16, 2021

1.5K
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

43.8K
Measurement of Cyclic Guanosine Monophosphate (cGMP) in Solid Tissues using Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
07:15

Measurement of Cyclic Guanosine Monophosphate (cGMP) in Solid Tissues using Competitive Enzyme-Linked Immunosorbent Assay (ELISA)

Published on: July 3, 2025

167

Area of Science:

  • Cell biology
  • Biochemistry
  • Molecular genetics

Background:

  • Biomolecular condensates (BMCs) regulate cellular functions through noncovalent interactions.
  • Tudor domain proteins, including SMN, bind to dimethylarginine (DMA) modifications, influencing BMC formation.
  • SMN deficiency causes spinal muscular atrophy (SMA), underscoring the importance of SMN function.

Purpose of the Study:

  • To explore the role of SMN's Tudor domain in forming cytoplasmic and nuclear BMCs.
  • To identify the largely unknown dimethylarginine (DMA) ligands of SMN.
  • To understand the impact of DMA modification on protein interactions and localization.

Main Methods:

  • Focus on Tudor domain-containing proteins, specifically SMN.
  • Investigating noncovalent interactions driving BMC formation.
  • Highlighting the need for direct DMA detection methods.

Main Results:

  • SMN is found in RNA-rich BMCs.
  • SMN's Tudor domain contributes to both cytoplasmic and nuclear BMC formation.
  • The specific DMA ligands for SMN remain largely unidentified.

Conclusions:

  • Understanding SMN's Tudor-DMA interactions is critical for elucidating SMN function and SMA pathogenesis.
  • DMA modification influences protein behavior, but direct detection methods are lacking.
  • Further research is needed to identify SMN's DMA ligands and their functional consequences.